Slideshow

July 30, 2018

7 New Drugs for Rheumatology in 2018

Here’s a brief look at medications for rheumatologic disorders that were approved or granted a new indication in 2018.

Related Videos

Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors

Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute

Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning

John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research

Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis

Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool

Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis

$Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome$

Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine

John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.